Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

SARS-CoV-2 NSP8 antibody (AA 3943-4140)

This Rabbit Polyclonal antibody specifically detects SARS-CoV-2 NSP8 in WB, ELISA and IHC. It exhibits reactivity toward SARS Coronavirus-2 (SARS-CoV-2).
Catalog No. ABIN7571261

Quick Overview for SARS-CoV-2 NSP8 antibody (AA 3943-4140) (ABIN7571261)

Target

See all SARS-CoV-2 NSP8 (NSP8) Antibodies
SARS-CoV-2 NSP8 (NSP8) (SARS-CoV-2 Non-Structural Protein 8 (NSP8))

Reactivity

  • 4
  • 2
SARS Coronavirus-2 (SARS-CoV-2)

Host

  • 4
  • 1
  • 1
Rabbit

Clonality

  • 5
  • 1
Polyclonal

Conjugate

  • 6
This SARS-CoV-2 NSP8 antibody is un-conjugated

Application

  • 4
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
  • Binding Specificity

    • 1
    • 1
    • 1
    AA 3943-4140

    Purpose

    Anti-NSP8 Polyclonal antibody

    Purification

    Antigen affinity purification.

    Immunogen

    E. coli - derived recombinant SARS-CoV-2 NSP8 (Ala3943-Gln4140).

    Isotype

    IgG
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    0.01M PBS, pH 7.4, 50 % glycerol, 0.05 % Proclin 300.

    Preservative

    ProClin

    Precaution of Use

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C,-20 °C,-80 °C

    Storage Comment

    Use a manual defrost freezer and avoid repeated freeze thaw cycles.Store at 4°C for frequent use.Store at -20 to -80 °C for twelve months from the date of receipt.
  • Target

    SARS-CoV-2 NSP8 (NSP8) (SARS-CoV-2 Non-Structural Protein 8 (NSP8))

    Alternative Name

    SARS-CoV-2 NSP8

    Target Type

    Viral Protein

    Background

    Non-structural protein 8,nsp8,Replicase polyprotein 1ab,pp1ab,ORF1ab polyprotein, SARS-like Coronaviruses

    UniProt

    P0DTD1
You are here:
Chat with us!